1. Nestle, U., Kremp, S., Schaefer-Schuler, A., et al. (2005) Comparison of different methods for delineation of F-18 FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med
46, 1342–8.
2. Senan, S., De Ruysscher, D., Giraud, P., Mirimanoff, R., Budach, V. Radiotherapy Group of European Organization for Research and Treatment of Cancer.(2004) Literature-based recommendations for treatment planning and execution for high-precision radiotherapy in lung cancer Radiother Oncol
71, 139–46.
3. Nestle, U., Kremp, S., Grosu, A.L. (2006) Practical integration of [18 F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol
81, 209–25.
4. van Der Wel, A., Nijsten, S., Hochstenbag, M., et al. (2005) Increased therapeutic ratio by 18FDG-PET-CT planning in patients with clinical CT stage N2/N3 M0 non-small cell lung cancer (NSCLC): A modelling study. Int J Radiat Oncol Biol Phys
61, 648–54.
5. De Ruysscher, D., Wanders, S., Minken, A., et al. (2005) Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: Results of a prospective study. Radiother Oncol
77, 5–10.